Ketryx, the AI-native compliance platform, has announced the details of its inaugural Validated AI Conference. This first-of-its-kind event is built for engineers, quality and regulatory leaders and AI professionals who are actively building AI systems in regulated environments, and know firsthand the challenges of shipping AI products that actually have to pass regulatory scrutiny. The conference will be held both in-person at the Massachusetts Institute of Technology (MIT) in Cambridge, MA, with a virtual attendance option available for remote participants.
The conference will take place on Thursday, April 9 at The Engine by MIT in Cambridge, Massachusetts. The event aims to unite professionals building AI in regulated industries and share practical frameworks for compliance and innovation. Attendees can expect to learn from industry experts about navigating the complexities of regulatory approval while maintaining the pace of innovation.
Ketryx transforms the product lifecycle of life science teams to deliver safer products, faster. Trusted by four of the world’s top five medical device manufacturers, its AI-native compliance platform overlays existing tools to automate documentation, create traceability, and accelerate release cycles—without disrupting existing workflows. Ketryx AI Agents cut manual work by 90 percent and close compliance gaps, elevating speed and quality across the entire product lifecycle. For more information, visit www.ketryx.com.
The Validated AI Conference represents a critical step for the industry, as regulatory bodies increasingly scrutinize AI-based products. By providing a forum for sharing best practices, the conference aims to help companies avoid costly compliance pitfalls while accelerating time to market. The event will feature keynote speakers, panel discussions, and workshops focused on real-world applications of AI in regulated environments.
Interested participants can register for the in-person or virtual event through the Ketryx website. The conference is expected to draw attendees from medical device, pharmaceutical, and other highly regulated sectors.
